Beijing Centergate Technologies Holding Co Ltd Cash Flow Conversion Efficiency

Latest as of September 2025: 0.001x

Beijing Centergate Technologies Holding Co Ltd cash flow conversion efficiency. Based on the latest financial reports, Beijing Centergate Technologies Holding Co Ltd (000931) has a cash flow conversion efficiency ratio of 0.001x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥1.86 Million ≈ $272.42K USD) by net assets (CN¥1.87 Billion ≈ $273.13 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Cash Flow Conversion Efficiency of Beijing Centergate Technologies Holding Co Ltd (2000–2024)

Cash flow conversion efficiency of Beijing Centergate Technologies Holding Co Ltd from 2000 to 2024. This chart illustrates how Beijing Centergate Technologies Holding Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. View current stock price of Beijing Centergate Technologies Holding for real-time trading data and today's change.

Beijing Centergate Technologies Holding Co Ltd Cash Flow Conversion Ratio Explained

Beijing Centergate Technologies Holding Co Ltd cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.

Beijing Centergate Technologies Holding Co Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Beijing Centergate Technologies Holding Co Ltd ranked by their cash flow conversion efficiency. Also see 000931 stock market capitalisation for the company's overall valuation and market capitalisation.

Company Cash Flow Conversion Efficiency
Apellis Pharmaceuticals Inc
NASDAQ:APLS
-0.147x
Sunplus Technology Co Ltd
TW:2401
0.018x
Ningbo Gaofa Automotive Ctrl
SHG:603788
0.067x
Kaili Catalyst & New Materials Co. Ltd. A
SHG:688269
0.008x
Dogu Aras Enerji Yatirimlari AS
IS:ARASE
0.075x
Facc AG
VI:FACC
0.002x
Jiangsu Lianfa Textile Co Ltd
SHE:002394
-0.002x
Landsea Homes Corp
NASDAQ:LSEA
-0.015x

Annual Cash Flow Conversion Efficiency for Beijing Centergate Technologies Holding Co Ltd (2000–2024)

The table below shows the annual cash flow conversion efficiency of Beijing Centergate Technologies Holding Co Ltd from 2000 to 2024. Review Beijing Centergate Technologies Holding free cash flow ratio to assess how much free cash flow the company generates relative to operating cash flow.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2024-12-31 CN¥1.81 Billion
≈ $264.42 Million
CN¥127.60 Million
≈ $18.67 Million
0.071x -43.81%
2023-12-31 CN¥1.74 Billion
≈ $254.18 Million
CN¥218.30 Million
≈ $31.94 Million
0.126x +14.37%
2022-12-31 CN¥1.67 Billion
≈ $244.69 Million
CN¥183.74 Million
≈ $26.89 Million
0.110x -24.35%
2021-12-31 CN¥1.81 Billion
≈ $265.37 Million
CN¥263.41 Million
≈ $38.55 Million
0.145x +38.64%
2020-12-31 CN¥1.91 Billion
≈ $279.62 Million
CN¥200.20 Million
≈ $29.30 Million
0.105x +18.51%
2019-12-31 CN¥1.86 Billion
≈ $271.73 Million
CN¥164.17 Million
≈ $24.02 Million
0.088x -18.45%
2018-12-31 CN¥1.89 Billion
≈ $277.03 Million
CN¥205.22 Million
≈ $30.03 Million
0.108x +22.23%
2017-12-31 CN¥1.79 Billion
≈ $262.01 Million
CN¥158.80 Million
≈ $23.24 Million
0.089x +391.59%
2016-12-31 CN¥1.07 Billion
≈ $156.12 Million
CN¥-32.45 Million
≈ $-4.75 Million
-0.030x -138.50%
2015-12-31 CN¥858.30 Million
≈ $125.60 Million
CN¥-10.95 Million
≈ $-1.60 Million
-0.013x +97.74%
2014-12-31 CN¥692.22 Million
≈ $101.29 Million
CN¥-391.31 Million
≈ $-57.26 Million
-0.565x -172.21%
2013-12-31 CN¥635.38 Million
≈ $92.98 Million
CN¥497.42 Million
≈ $72.79 Million
0.783x +2288.92%
2012-12-31 CN¥829.77 Million
≈ $121.42 Million
CN¥-29.68 Million
≈ $-4.34 Million
-0.036x -111.63%
2011-12-31 CN¥791.81 Million
≈ $115.87 Million
CN¥243.58 Million
≈ $35.64 Million
0.308x +46.59%
2010-12-31 CN¥874.85 Million
≈ $128.02 Million
CN¥183.58 Million
≈ $26.86 Million
0.210x -3.21%
2009-12-31 CN¥858.96 Million
≈ $125.69 Million
CN¥186.23 Million
≈ $27.25 Million
0.217x -11.67%
2008-12-31 CN¥798.63 Million
≈ $116.86 Million
CN¥196.03 Million
≈ $28.69 Million
0.245x -68.95%
2007-12-31 CN¥911.32 Million
≈ $133.35 Million
CN¥720.54 Million
≈ $105.44 Million
0.791x +757.71%
2006-12-31 CN¥659.01 Million
≈ $96.43 Million
CN¥-79.22 Million
≈ $-11.59 Million
-0.120x -134.29%
2005-12-31 CN¥665.70 Million
≈ $97.41 Million
CN¥233.41 Million
≈ $34.16 Million
0.351x +70.68%
2004-12-31 CN¥1.19 Billion
≈ $174.06 Million
CN¥244.35 Million
≈ $35.76 Million
0.205x +78.57%
2003-12-31 CN¥1.36 Billion
≈ $198.65 Million
CN¥156.17 Million
≈ $22.85 Million
0.115x +193.40%
2002-12-31 CN¥2.03 Billion
≈ $297.22 Million
CN¥-250.19 Million
≈ $-36.61 Million
-0.123x -248.16%
2001-12-31 CN¥2.31 Billion
≈ $337.99 Million
CN¥192.03 Million
≈ $28.10 Million
0.083x +113.71%
2000-12-31 CN¥2.13 Billion
≈ $311.53 Million
CN¥-1.29 Billion
≈ $-188.85 Million
-0.606x --

About Beijing Centergate Technologies Holding Co Ltd

SHE:000931 China Medical Instruments & Supplies
Market Cap
$412.17 Million
CN¥2.82 Billion CNY
Market Cap Rank
#12891 Global
#3761 in China
Share Price
CN¥3.74
Change (1 day)
-0.27%
52-Week Range
CN¥3.73 - CN¥5.70
All Time High
CN¥12.90
About

Beijing Centergate Technologies (holding) Co., Ltd. engages in the pharmaceutical industry in China and internationally. The company offers Anemarrhena saponin BII and capsules for vascular dementia treatment; Bifonazole API, an opioid receptor antagonist; Naloxone Hydrochloride injection to relieve acute ethanol poisoning; Naltrexone Hydrochloride tablets to block the pharmacological effects of … Read more